NutriBand (NTRB) EBITDA Margin (2018 - 2026)
NutriBand's (NTRB) quarterly EBITDA Margin came in at 254.78% in Q1 2026, up 61057.0% year-on-year from N/an in Q1 2025, and up 77.28% quarter-over-quarter from 1121.3% in Q4 2025.
NutriBand (NTRB) EBITDA Margin (2018 - 2026) Analysis & Trends
NutriBand has disclosed EBITDA Margin across 9 years of filings, most recently posting 254.78% for Q1 2026.
- EBITDA Margin for Q1 2026 came in at 254.78%, up 61057.0% year-over-year; the trailing twelve-month figure through Jan 2026 was 408.41% (up 7229.0% YoY), and the FY2026 annual result was 408.41%, up 7229.0% from the prior year.
- EBITDA Margin came in at 254.78% for Q1 2026 at NutriBand, up from 1121.3% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 126.41% in Q3 2023 to a low of 1121.3% in Q4 2025.
- The 5-year median for EBITDA Margin is 254.78% (2026), against an average of 378.73%.
- Across the five-year window, EBITDA Margin slumped 90035 bps in 2025 and surged 61057 bps in 2026, its largest moves.
- NutriBand's EBITDA Margin stood at 174.03% in 2022, then sank by 131 bps to 402.84% in 2023, then soared by 45 bps to 220.94% in 2024, then plunged by 408 bps to 1121.3% in 2025, then soared by 77 bps to 254.78% in 2026.
- The last three EBITDA Margin figures came in at 254.78% (Q1 2026), 1121.3% (Q4 2025), and 321.83% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -6.43% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 | -254.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -254.78% |
| Oct 31, 2025 | -1,121.30% |
| Jul 31, 2025 | -321.83% |
| Apr 30, 2025 | -211.78% |
| Jan 31, 2025 | -865.34% |
| Oct 31, 2024 | -220.94% |
| Jul 31, 2024 | -318.35% |
| Apr 30, 2024 | -462.50% |
| Jan 31, 2024 | -249.01% |
| Oct 31, 2023 | -402.84% |
| Jul 31, 2023 | -126.41% |
| Apr 30, 2023 | -212.87% |
| Jan 31, 2023 | -318.33% |
| Oct 31, 2022 | -174.03% |
| Jul 31, 2022 | -227.71% |
| Apr 30, 2022 | -144.37% |
| Jan 31, 2022 | -806.08% |
| Oct 31, 2021 | -555.34% |
| Jul 31, 2021 | -243.25% |
| Apr 30, 2021 | -72.68% |